MedTrace Logo

Comparison of Nikkomycin Z Bioavailability Under Fed and Fasting Conditions

NCT01647256 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2013-09-17

No results posted yet for this study

Summary

The primary purpose of this study is to evaluate if eating a high fat meal versus not eating any food affects how the study drug (Nikkomycin Z) is absorbed into the body. The second purpose is to gain further information about the safety of Nikkomycin Z in healthy adults.

Conditions

  • Healthy

Interventions

DRUG

Nikkomycin Z

Capsule, 500 mg, single-dose

Sponsors & Collaborators

  • University of Arizona

    lead OTHER

Principal Investigators

  • Kathryn R Matthias, PharmD · University of Arizona

  • David E Nix, PharmD · University of Arizona

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2012-08-31
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01647256 on ClinicalTrials.gov